Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2041-1723

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer ; volume:10 ; number:1 ; day:23 ; month:1 ; year:2019 ; pages:1-12 ; date:12.2019
Nature Communications ; 10, Heft 1 (23.1.2019), 1-12, 12.2019

Classification: Naturwissenschaften

Creator: Annunziato, Stefano
de Ruiter, Julian R.
Henneman, Linda
Brambillasca, Chiara S.
Lutz, Catrin
Vaillant, François
Ferrante, Federica
Drenth, Anne Paulien
van der Burg, Eline
Siteur, Bjørn
van Gerwen, Bas
de Bruijn, Roebi
van Miltenburg, Martine H.
Huijbers, Ivo J.
van de Ven, Marieke
Visvader, Jane E.
Lindeman, Geoffrey J.
Wessels, Lodewyk F. A.
Jonkers, Jos

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41467-019-08301-2

URN: urn:nbn:de:101:1-2019021823371889915859

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:01 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Annunziato, Stefano
de Ruiter, Julian R.
Henneman, Linda
Brambillasca, Chiara S.
Lutz, Catrin
Vaillant, François
Ferrante, Federica
Drenth, Anne Paulien
van der Burg, Eline
Siteur, Bjørn
van Gerwen, Bas
de Bruijn, Roebi
van Miltenburg, Martine H.
Huijbers, Ivo J.
van de Ven, Marieke
Visvader, Jane E.
Lindeman, Geoffrey J.
Wessels, Lodewyk F. A.
Jonkers, Jos
SpringerLink (Online service)

Other Objects (12)

Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers

Transcriptome Patterns of BRCA1- and BRCA2- Mutated Breast and Ovarian Cancers

Analysis of SLX4/FANCP in non-BRCA1/2-mutated breast cancer families

Effects on human transcriptome of mutated BRCA1 BRCT domain: A microarray study

PARP inhibition radiosensitizes BRCA1 wildtype and mutated breast cancer to proton therapy

Transcriptional Response to Standard AML Drugs Identifies Synergistic Combinations

Drug and disease signature integration identifies synergistic combinations in glioblastoma

Interactions of BRCA1-mutated Breast Cancer Cell Lines with Adipose-derived Stromal Cells (ADSCs)

Multi-omics analysis identifies drivers of protein phosphorylation

Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy

Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines

Driver gene combinations dictate cutaneous squamous cell carcinoma disease continuum progression

Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers

Transcriptome Patterns of BRCA1- and BRCA2- Mutated Breast and Ovarian Cancers

Analysis of SLX4/FANCP in non-BRCA1/2-mutated breast cancer families

Effects on human transcriptome of mutated BRCA1 BRCT domain: A microarray study

PARP inhibition radiosensitizes BRCA1 wildtype and mutated breast cancer to proton therapy

Transcriptional Response to Standard AML Drugs Identifies Synergistic Combinations

Drug and disease signature integration identifies synergistic combinations in glioblastoma

Interactions of BRCA1-mutated Breast Cancer Cell Lines with Adipose-derived Stromal Cells (ADSCs)

Multi-omics analysis identifies drivers of protein phosphorylation

Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy

Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines

Driver gene combinations dictate cutaneous squamous cell carcinoma disease continuum progression

Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers

Transcriptome Patterns of BRCA1- and BRCA2- Mutated Breast and Ovarian Cancers

Analysis of SLX4/FANCP in non-BRCA1/2-mutated breast cancer families

Effects on human transcriptome of mutated BRCA1 BRCT domain: A microarray study

PARP inhibition radiosensitizes BRCA1 wildtype and mutated breast cancer to proton therapy

Transcriptional Response to Standard AML Drugs Identifies Synergistic Combinations

Drug and disease signature integration identifies synergistic combinations in glioblastoma

Interactions of BRCA1-mutated Breast Cancer Cell Lines with Adipose-derived Stromal Cells (ADSCs)

Multi-omics analysis identifies drivers of protein phosphorylation

Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy

Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines

Driver gene combinations dictate cutaneous squamous cell carcinoma disease continuum progression

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers

Transcriptome Patterns of BRCA1- and BRCA2- Mutated Breast and Ovarian Cancers

Analysis of SLX4/FANCP in non-BRCA1/2-mutated breast cancer families

Effects on human transcriptome of mutated BRCA1 BRCT domain: A microarray study

PARP inhibition radiosensitizes BRCA1 wildtype and mutated breast cancer to proton therapy

Transcriptional Response to Standard AML Drugs Identifies Synergistic Combinations

Drug and disease signature integration identifies synergistic combinations in glioblastoma

Interactions of BRCA1-mutated Breast Cancer Cell Lines with Adipose-derived Stromal Cells (ADSCs)

Multi-omics analysis identifies drivers of protein phosphorylation

Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy

Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines

Driver gene combinations dictate cutaneous squamous cell carcinoma disease continuum progression

Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers

Transcriptome Patterns of BRCA1- and BRCA2- Mutated Breast and Ovarian Cancers

Analysis of SLX4/FANCP in non-BRCA1/2-mutated breast cancer families

Effects on human transcriptome of mutated BRCA1 BRCT domain: A microarray study

PARP inhibition radiosensitizes BRCA1 wildtype and mutated breast cancer to proton therapy

Transcriptional Response to Standard AML Drugs Identifies Synergistic Combinations

Drug and disease signature integration identifies synergistic combinations in glioblastoma

Interactions of BRCA1-mutated Breast Cancer Cell Lines with Adipose-derived Stromal Cells (ADSCs)

Multi-omics analysis identifies drivers of protein phosphorylation

Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy

Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines

Driver gene combinations dictate cutaneous squamous cell carcinoma disease continuum progression

Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers

Transcriptome Patterns of BRCA1- and BRCA2- Mutated Breast and Ovarian Cancers

Analysis of SLX4/FANCP in non-BRCA1/2-mutated breast cancer families

Effects on human transcriptome of mutated BRCA1 BRCT domain: A microarray study

PARP inhibition radiosensitizes BRCA1 wildtype and mutated breast cancer to proton therapy

Transcriptional Response to Standard AML Drugs Identifies Synergistic Combinations

Drug and disease signature integration identifies synergistic combinations in glioblastoma

Interactions of BRCA1-mutated Breast Cancer Cell Lines with Adipose-derived Stromal Cells (ADSCs)

Multi-omics analysis identifies drivers of protein phosphorylation

Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy

Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines

Driver gene combinations dictate cutaneous squamous cell carcinoma disease continuum progression

Related objects

Reset password